CARMEN HERRING: Open Payments
NPI 1700236908 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 46 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $502 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $395 |
| Ferring Pharmaceuticals Inc. | 8 | $145 |
| Janssen Biotech, Inc. | 6 | $113 |
| TOLMAR, INC. | 3 | $69 |
| Astellas Pharma US Inc | 3 | $66 |
| Boston Scientific Corporation | 2 | $33 |
| Endo USA, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Procept Biorobotics Corporation | 1 | $15 |
| Laborie Medical Technologies Corp. | 1 | $14 |
Products named: GEMTESA, ADSTILADRIN, ERLEADA, Xtandi, ELIGARD, ORGOVYX, Axonics, JATENZO.
Industry payments across AL — which companies pay providers there.
